Endovascular Today

@EVToday

Covering minimally invasive vascular disease therapies and providing the latest clinical data, commentaries, and regulatory news.

Fort Washington, PA USA evtoday.com/subscribe Joined April 2011

2.3K Following 15K Followers 7.5K Posts

Latest posts 5

Endovascular Today @EVToday 2d

Drs. Irina Kanzafarova (@I_Y_Kanzafarova) & Michael Stoner draw on their high-volume center’s experience to offer practical guidance for optimizing TCAR, including preop prep, operating room setup, team communication, carotid access, & procedural technique evtoday.com/articles/2026-…

evtoday.com TCAR Mastery: Five Technical Tips for Successful Outcomes - Endovascular Today Practical guidance from a high-volume center on procedural planning, team coordination, carotid access, and technical execution of TCAR.

Endovascular Today @EVToday 3d

Treating the clot and the cause. Explore early real-world experience with the Liberant™ thrombectomy system, case-based strategies, and physician perspectives on peripheral thrombectomy. | #Sponsored by @Medtronic evtoday.com/issues/2026-oc…

evtoday.com October 2026 Supplement - Endovascular Today News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

Endovascular Today @EVToday 3d

CereVasc’s eShunt System Receives IDE Approval for Study in Early Symptomatic Alzheimer Disease | @CereVasc evtoday.com/news/cerevascs…

evtoday.com CereVasc’s eShunt System Receives IDE Approval for Study in Early Symptomatic Alzheimer Disease -... November 4, 2026—CereVasc, Inc. announced that the FDA approved an investigational device exemption application to evaluate the company’s

Endovascular Today @EVToday 4d

Study Reports Low Operator Radiation Exposure With RAMPART Guardian System | Presented at #TCT2026
evtoday.com/news/study-rep…

evtoday.com Study Reports Low Operator Radiation Exposure With Rampart Guardian System - Endovascular Today November 4, 2026—An observational study evaluating operator radiation exposure during endovascular procedures with the Rampart Guardian shieldin

Endovascular Today @EVToday 4d

Nadine Abi-Jaoudeh, MD; Zachary T. Berman, MD (@ZTBerman); and Ammar Sarwar, MD (@AmmarSarwarIRad), discuss where their approaches to yttrium-90, conventional transarterial chemoembolization, and ablation for hepatocellular carcinoma converge and differ. evtoday.com/articles/2026-…

evtoday.com Liver-Directed Therapy in 2026: Redefining the Roles of Y90, cTACE, and Ablation in HCC - Endovas... Perspectives on patient selection, treatment sequencing, combination strategies, and the growing influence of systemic therapy.